DK1078006T3 - Diagnose og behandling af leverlidelser - Google Patents
Diagnose og behandling af leverlidelserInfo
- Publication number
- DK1078006T3 DK1078006T3 DK99922996T DK99922996T DK1078006T3 DK 1078006 T3 DK1078006 T3 DK 1078006T3 DK 99922996 T DK99922996 T DK 99922996T DK 99922996 T DK99922996 T DK 99922996T DK 1078006 T3 DK1078006 T3 DK 1078006T3
- Authority
- DK
- Denmark
- Prior art keywords
- disorders
- madcam
- disorder
- compositions
- useful
- Prior art date
Links
- 208000019423 liver disease Diseases 0.000 title abstract 2
- 238000003745 diagnosis Methods 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 6
- 208000035475 disorder Diseases 0.000 abstract 5
- 238000000034 method Methods 0.000 abstract 3
- 230000003993 interaction Effects 0.000 abstract 2
- 239000003446 ligand Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 102000016289 Cell Adhesion Molecules Human genes 0.000 abstract 1
- 108010067225 Cell Adhesion Molecules Proteins 0.000 abstract 1
- 208000028782 Hereditary disease Diseases 0.000 abstract 1
- 208000019468 Iatrogenic Disease Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 230000000903 blocking effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000001587 cholestatic effect Effects 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000028709 inflammatory response Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 201000000306 sarcoidosis Diseases 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70546—Integrin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Transplantation (AREA)
- Biotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7840598A | 1998-05-13 | 1998-05-13 | |
| PCT/US1999/010520 WO1999058573A1 (fr) | 1998-05-13 | 1999-05-12 | Diagnostic et traitement des troubles hepatiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1078006T3 true DK1078006T3 (da) | 2009-06-02 |
Family
ID=22143829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99922996T DK1078006T3 (da) | 1998-05-13 | 1999-05-12 | Diagnose og behandling af leverlidelser |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1078006B1 (fr) |
| JP (2) | JP4817494B2 (fr) |
| AT (1) | ATE424417T1 (fr) |
| AU (1) | AU3986699A (fr) |
| CA (1) | CA2330000C (fr) |
| DE (1) | DE69940503D1 (fr) |
| DK (1) | DK1078006T3 (fr) |
| ES (1) | ES2321994T3 (fr) |
| IL (2) | IL139129A0 (fr) |
| WO (1) | WO1999058573A1 (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE319997T1 (de) * | 2001-11-05 | 2006-03-15 | Warner Lambert Co | Screeningverfahren für modulatoren von integrinen |
| WO2004081049A1 (fr) * | 2003-03-10 | 2004-09-23 | Auckland Uniservices Limited | Anticorps monoclonaux reconnaissant la molecule d'adherence cellulaire d'adressine des muqueuses, forme soluble de madcam-1, et utilisations |
| ZA200605825B (en) * | 2004-01-09 | 2007-11-28 | Pfizer | Antibodies to madcam |
| ES2351057T3 (es) * | 2005-07-08 | 2011-01-31 | Pfizer Limited | Anticuerpos contra madcam. |
| ES2997080T3 (en) * | 2010-10-25 | 2025-02-14 | Biogen Ma Inc | Methods for determining differences in alpha-4 integrin activity by correlating differences in svcam and/or smadcam levels |
| MA41636A (fr) * | 2015-03-06 | 2018-01-09 | Millennium Pharm Inc | Méthode de traitement de la cholangite sclérosante primitive |
| JP6970975B2 (ja) * | 2016-07-20 | 2021-11-24 | 国立大学法人京都大学 | ＩｇＧ４関連疾患の検査方法 |
| US20190169291A1 (en) | 2017-07-14 | 2019-06-06 | Pfizer Inc. | Antibodies to MAdCAM |
| WO2019113280A1 (fr) * | 2017-12-06 | 2019-06-13 | Emory University | Méthodes de gestion de la stéatose hépatique |
| AU2024282654A1 (en) | 2023-05-30 | 2025-12-04 | Paragon Therapeutics, Inc. | Alpha4beta7 integrin antibody compositions and methods of use |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2212702C (fr) * | 1995-02-10 | 2010-04-20 | Leukosite, Inc. | Adressines vasculaires de muqueuses et leurs utilisations |
| US6037324A (en) * | 1996-01-04 | 2000-03-14 | Leukosite, Inc. | Inhibitors of MAdCAM-1-mediated interactions and methods of use therefor |
-
1999
- 1999-05-12 DK DK99922996T patent/DK1078006T3/da active
- 1999-05-12 EP EP99922996A patent/EP1078006B1/fr not_active Expired - Lifetime
- 1999-05-12 DE DE69940503T patent/DE69940503D1/de not_active Expired - Lifetime
- 1999-05-12 AT AT99922996T patent/ATE424417T1/de not_active IP Right Cessation
- 1999-05-12 WO PCT/US1999/010520 patent/WO1999058573A1/fr not_active Ceased
- 1999-05-12 IL IL13912999A patent/IL139129A0/xx active IP Right Grant
- 1999-05-12 ES ES99922996T patent/ES2321994T3/es not_active Expired - Lifetime
- 1999-05-12 AU AU39866/99A patent/AU3986699A/en not_active Abandoned
- 1999-05-12 CA CA2330000A patent/CA2330000C/fr not_active Expired - Lifetime
- 1999-05-12 JP JP2000548375A patent/JP4817494B2/ja not_active Expired - Lifetime
-
2000
- 2000-10-18 IL IL139129A patent/IL139129A/en not_active IP Right Cessation
-
2010
- 2010-06-04 JP JP2010129284A patent/JP2010280659A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2010280659A (ja) | 2010-12-16 |
| EP1078006B1 (fr) | 2009-03-04 |
| ES2321994T3 (es) | 2009-06-15 |
| CA2330000A1 (fr) | 1999-11-18 |
| EP1078006A1 (fr) | 2001-02-28 |
| CA2330000C (fr) | 2015-06-23 |
| AU3986699A (en) | 1999-11-29 |
| DE69940503D1 (de) | 2009-04-16 |
| ATE424417T1 (de) | 2009-03-15 |
| JP4817494B2 (ja) | 2011-11-16 |
| IL139129A (en) | 2006-09-05 |
| JP2002514660A (ja) | 2002-05-21 |
| IL139129A0 (en) | 2001-11-25 |
| WO1999058573A1 (fr) | 1999-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Heneka et al. | Neuroinflammation in Alzheimer's disease | |
| BRPI0413326A (pt) | métodos para tratar doença cardiovasculares empregando-se uma molécula ctla4 solúvel | |
| DK1078006T3 (da) | Diagnose og behandling af leverlidelser | |
| BR0011000A (pt) | Métodos para prevenir ou tratar uma doença associada com depósitos amilóides de ab no cérebro de um paciente, para avaliar um anticorpo quanto á atividade de remoção de uma entidade biológica fisicamente associada com um antìgeno e para detectara um depósito amilóide em um paciente, composição farmacêutica, e, conjunto de diagnóstico | |
| BR0211062A (pt) | Combinações para o tratamento de distúrbios inflamatórios | |
| DE69833971D1 (de) | Verfahren zur behandlung von alzheimerschen krankheit | |
| BRPI0712322A2 (pt) | compostos e combinações destes para a inibição da produção de beta-amilóide e métodos de uso dos mesmos | |
| NO20050807L (no) | Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser | |
| BRPI0206641B8 (pt) | uso de um inibidor da absorção de esteróis | |
| ATE510538T1 (de) | Zusammensetzungen und verfahren für nervenschutz | |
| WO2007103373A3 (fr) | Compositions et procédés pour le traitement de troubles immunoinflammatoires | |
| MA28935B1 (fr) | Preparation et utilisation de derives de biphenyl-4-yl-carbonylamino-acide dans le traitement de l'obesite | |
| BRPI0606902A2 (pt) | composto; método para o tratamento de uma doença ou distúrbio associado a atividade excessiva de bace em um paciente que dele necessite; método para modular a atividade de bace; composição farmacêutica | |
| BR0308290A (pt) | Tratamento e prevenção de distúrbios inflamatórios | |
| BRPI0413745A (pt) | horário mde dosagem para agentes anticancerìgenos erbb2 | |
| BRPI0418384A (pt) | composições farmacêuticas e métodos referentes à inibição de adesões fibrosas utilizando diversos agentes | |
| Sewal et al. | Increase in seizure susceptibility in sepsis like condition explained by spiking cytokines and altered adhesion molecules level with impaired blood brain barrier integrity in experimental model of rats treated with lipopolysaccharides | |
| ATE497763T1 (de) | Verfahren und reagenzien zur behandlung von entzündlichen erkrankungen | |
| WO2008157747A8 (fr) | Utilisation d'inhibition d'exonucléase i dans des procédés de thérapie et de diagnostic de maladies neurodégénératives, de maladies oculaires et de troubles mitochondriaux | |
| EA200101212A1 (ru) | Замещенные полициклические арил- и гетероарилпиразиноны, которые могут использоваться при селективном ингибировании системы свертывания крови | |
| WO2004064869A3 (fr) | Agent de chelation metallique, a liaison amyloide | |
| WO2005023189A3 (fr) | Procede de prevention ou de traitement de la douleur, de l'inflammation, et de troubles lies a l'inflammation avec un inhibiteur selectif de cox-2 en combinaison avec un agent donneur de monoxyde d'azote et compositions en contenant | |
| DE69426767D1 (de) | Anti idiotypische Antikörper gegen Gonococcen und diese verwendende Verfahren und Zusammensetzungen. | |
| BRPI0416591A (pt) | métodos e reagentes para o tratamento de distúrbios inflamatórios | |
| FI955261A0 (fi) | P-selektiinin vasta-aineita ja niiden käyttö |